Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -61.09% is 35% above its 2-year average of -94.10%, around the middle of its 2-year range (-462.87%–118.01%).
1.75% below its 12-month average of -60.04%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -58.27%.
OPERATING MARGIN
-61.09%
OPERATING MARGIN AVG TTM
-60.04%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1.75%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$402.49M
Operating Margin
0.00%
TTM Avg
-4465.14%
3Y Avg
-2232.57%
5Y Avg
-1488.38%
Market Cap
$405.51M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.78%
Market Cap
$407.02M
Operating Margin
-12.22%
TTM Avg
-9.37%
3Y Avg
-14.04%
5Y Avg
-19.79%
Market Cap
$398.17M
Operating Margin
-58.53%
TTM Avg
-50.96%
3Y Avg
-52.76%
5Y Avg
-52.76%
Market Cap
$410.03M
Operating Margin
-7.97%
TTM Avg
-12.49%
3Y Avg
-22.96%
5Y Avg
-27.91%
Market Cap
$408.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$412.06M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Carlsmed, Inc. (CARL) | $401.52M | -61.09% | -60.04% | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $404.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| Neurogene Inc. (NGNE)vs › | $402.49M | 0.00% | -4465.14% | -2232.57% | -1488.38% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.51M | 0.00% | 0.00% | 0.00% | 2.78% |
| Myriad Genetics, Inc. (MYGN)vs › | $407.02M | -12.22% | -9.37% | -14.04% | -19.79% |
| Shoulder Innovations, Inc. (SI)vs › | $398.17M | -58.53% | -50.96% | -52.76% | -52.76% |
| Strata Critical Medical, Inc. (SRTA)vs › | $410.03M | -7.97% | -12.49% | -22.96% | -27.91% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $412.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Prothena Corporation plc (PRTA)vs › | $418.30M | -1905.82% | -1010.09% | -618.33% | -2608.93% |
Gross Margin
76.6%
Operating Margin
-61.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -58.27% |
| 2026-03-31 | -57.56% |
| 2025-12-31 | -61.44% |
| 2025-09-30 | -69.11% |
| 2025-06-30 | -53.81% |
| 2025-03-31 | -56.13% |
| 2024-12-31 | -462.87% |
| 2024-09-30 | 118.01% |
| 2024-06-30 | -103.91% |
| 2024-03-31 | -104.78% |
| 2023-12-31 | -125.28% |
